Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia
Sameem M. Abedin
Guru Subramanian Guru Murthy
Mehdi Hamadani
Laura C. Michaelis
Karen-Sue Carlson
Lyndsey Runaas
Katelyn Gauger
Avinash G. Desai
Mary M. Chen
Kate L. Li
Mojisola Rotibi
Umar Syed
Madhuri Vusirikala
Alexandra Harrington
Ehab L. Atallah
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41375-025-02528-3
Feb 15, 2025
Version published to 10.21203/rs.3.rs-5368989/v1 on Research Square
Dec 1, 2024
Related articles
Efficacy and Safety of the Combination of Durvalumab plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: A Real-World Study
This article has 12 authors:
Eishin Kurihara
Satoru Kakizaki
Masashi Ijima
Takeshi Hatanaka
Norio Kubo
Yuhei Suzuki
Hidetoshi Yasuoka
Takashi Hoshino
Atsushi Naganuma
Noriyuki Tani
Yuichi Yamazaki
Toshio Uraoka
De-escalated Teclistamab Dosing in Relapsed/Refractory Multiple Myeloma: Czech Myeloma Group Real- World Evidence Analysis
This article has 21 authors:
Martin Stork
Jakub Radocha
Jana Mihalyova
Ivan Spicka
Tomas Pika
Alexandra Jungova
Ivanna Boichuk
Klara Mensikova
Jan Straub
Frantisek Sedlak
Jiri Minarik
Petra Krhovska
Denisa Novakova
Michaela Hornakova
Zdenka Knechtova
Nela Sendlerova
Tereza Dekojova
Vladimir Maisnar
Tomas Jelinek
Roman Hajek
Ludek Pour
Anlotinib Plus Camrelizumab And Chemotherapy As First-Line Treatment In Patients With Advanced Esophageal Squamous Cell Carcinoma
This article has 7 authors:
Mingfang Xu
Yu Pu
Yuzhu Jiang
Yingda Liu
Yan Feng
Xiaodong Zhao
Mengxia Li
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up